Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|November 12, 2010
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 proteaseCharles Z Ding, Yong-Kang Zhang, Xianfeng Li, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2010
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Journal of Medicinal Chemistry|April 5, 2012
Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutantsWieslaw M Kazmierski, Robert Hamatake, Maosheng Duan, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groupsXianfeng Li, Yang Liu, Yong-Kang Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moietiesXianfeng Li, Suoming Zhang, Yong-Kang Zhang, et al.
Plos Neglected Tropical Diseases|July 9, 2011
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasisRobert T Jacobs, Bakela Nare, Stephen A Wring, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronatesXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteriaVincent Hernandez, Thibaut Crépin, Andrés Palencia, et al.
Pageof 6